The Centre for Commercialization of Regenerative Medicine (CCRM) Australia has partnered with local and international venture capital firms to launch the National Regenerative Medicine SuperPitch. The SuperPitch offers expertise and investment funding for translation and commercialisation of Australian projects related to regenerative medicine.
Regenerative medicine includes technologies and therapies that regenerate or replace injured, diseased, or defective cells, tissues, or organs to restore or establish function and structure. Submissions may relate to cell therapies, gene therapies, combination therapies, gene editing tools, enabling technologies such as vector production, automated analytical assays, biosensors, novel media, and other projects related to regenerative medicine in a wide range of therapeutic area.
The National Regenerative Medicine SuperPitch provides an opportunity for companies and researchers to showcase their technologies or ideas. Expert feedback, commercialisation support from CCRM Australia and, for suitable projects, further development funding will be made available. The participation of partners with expertise in various specialties and lifecycle stages empowers the SuperPitch to streamline progress from proof of concept through to clinical trials.
Shortlisted applicants will be invited to provide a forty-minute presentation, which must include objective data on their technologies to a panel of regenerative medicine, venture capital and commercialisation experts from the consortia.
The inaugural National Regenerative Medicine SuperPitch will be held on the 24th of July 2020. If the ongoing COVID-19 pandemic allows, the event will be held at the Monash Conference Centre, 30 Collins St, Melbourne. Either way, video conference facilities will be made available for all participants.
- Application via expression of interest close 5 pm AEST 5th June 2020
- Shortlisted applicants will be informed during the week commencing 29th June 2020
- SuperPitch event: 24th July
For more information and to apply please refer to the program flyer and Expressions of Interest form.
Frequently Asked Questions
Contact: Dr Jack Lambshead, email@example.com.